BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28194418)

  • 1. Antineoplastic Effects of Honokiol on Melanoma.
    Guillermo-Lagae R; Santha S; Thomas M; Zoelle E; Stevens J; Kaushik RS; Dwivedi C
    Biomed Res Int; 2017; 2017():5496398. PubMed ID: 28194418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
    Ishikawa C; Arbiser JL; Mori N
    Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
    Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
    Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
    Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
    Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
    Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
    Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER; Arlotti JA; Marynowski SW; Singh SV
    Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
    Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
    Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol produces anti-neoplastic effects on melanoma cells in vitro.
    Mannal PW; Schneider J; Tangada A; McDonald D; McFadden DW
    J Surg Oncol; 2011 Sep; 104(3):260-4. PubMed ID: 21472732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
    Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML
    Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
    Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
    Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
    Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X
    World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
    BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
    BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
    Prasad R; Kappes JC; Katiyar SK
    Oncotarget; 2016 Feb; 7(7):7899-912. PubMed ID: 26760964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.